Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2017 1
2019 2
2020 1
2021 1
2022 4
2023 6
2024 1
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Identification of metabolic pathways contributing to ER+ breast cancer disparities using a machine-learning pipeline.
Santaliz-Casiano A, Mehta D, Danciu OC, Patel H, Banks L, Zaidi A, Buckley J, Rauscher GH, Schulte L, Weller LR, Taiym D, Liko-Hazizi E, Pulliam N, Friedewald SM, Khan S, Kim JJ, Gradishar W, Hegerty S, Frasor J, Hoskins KF, Madak-Erdogan Z. Santaliz-Casiano A, et al. Among authors: danciu oc. Sci Rep. 2023 Jul 26;13(1):12136. doi: 10.1038/s41598-023-39215-1. Sci Rep. 2023. PMID: 37495653 Free PMC article.
Multiomic Analysis Links Neighborhood Disadvantage to Inflammatory Proteins and Tumorigenic Markers in ER+ Breast Cancer Plasma and Tumor Samples.
Heath H, Santaliz Casiano A, Fazli F, McGee H, Geise MW, Abrol E, Danciu OC, Rauscher GH, Zaidi A, Pulliam N, Liko Hazizi E, Friedewald S, Khan S, Kim JJ, Gradishar W, Frasor J, Hoskins KF, Madak-Erdogan Z. Heath H, et al. Among authors: danciu oc. J Proteome Res. 2025 Oct 3;24(10):5083-5098. doi: 10.1021/acs.jproteome.5c00447. Epub 2025 Sep 2. J Proteome Res. 2025. PMID: 40891367 Free PMC article.
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas.
Holdhoff M, Nicholas MK, Peterson RA, Maraka S, Liu LC, Fischer JH, Wefel JS, Fan TM, Vannorsdall T, Russell M, Iacoboni M, Tarasow TM, Hergenrother PJ, Dudek AZ, Danciu OC. Holdhoff M, et al. Among authors: danciu oc. Neurooncol Adv. 2023 Jul 19;5(1):vdad087. doi: 10.1093/noajnl/vdad087. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37554223 Free PMC article.
16 results